0 items USD 0.00Search
Your search for "delveinsight meningitis global api manufacturers marketed phase iii drugs landscape 2015" gave back 330 results.
Important bispecific antibody targets are basically in clinical practice, and many momentous bispecific antibodies will be born in the future. The...
Catalog:
AEI
June 2021
Price: USD 3,000.00
Active Pharmaceutical Ingredients (APIs) are active substances in a drug intended to achieve pharmacological activity which is having a direct effect...
Catalog:
IQ4I
March 2021
Price: USD 4,950.00
Global Clinical Trials - Current Trends and Recent Advancement Summary GBI Research’s latest report, Global Clinical Trials - Current Trends and...
Catalog:
CBR Pharma Insights
January 2019
Price: USD 2,995.00
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Artificial Intelligence Screening Drugs...
Catalog:
9Dimen Research
July 2020
Price: USD 2,850.00
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Artificial Intelligence Drug R&D Report...
Catalog:
9Dimen Research
July 2020
Price: USD 2,850.00
Pharmaceutical excipients are inactive substances in the drug which helps in modulating solubility, bioavailability, and stability of active...
IQ4I
July 2019
Price: USD 4,950.00
This report provides you with a landscape description and analysis of discovery and development of claudin 18.2 (CLDN18.2)-targeted antibody and cell...
Catalog:
La Merie Publishing
August 2023
Price: USD 2,365.00
COVID-19 Vaccines - Big Pharma and Biotech Race to make Vaccines available by the end of 2020 Summary The demand for a vaccine for the COVID-19 virus...
Catalog:
MarketLine
July 2020
Price: USD 995.00
Emerging Gene Therapies - Trends within the Technological, Clinical, Regulatory and Competitive Landscape Summary GBI Research’s latest report “...
Catalog:
CBR Pharma Insights
January 2019
Price: USD 2,995.00
“Lutetium-177 Global Market Analysis” gives comprehensive insights on the various Lu-177 based drugs being developed for the treatment of GEP-NET,...
IQ4I
February 2020
Price: USD 3,600.00
T-Cell & NK-Cell Engaging Bispecific Antibo dies 2019: a business, stakeholder, technology and pipeline analysis report provides you with a...
Catalog:
La Merie Publishing
June 2019
Price: USD 2,700.00
“Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH...
IQ4I
October 2019
Price: USD 3,600.00
Innovation Tracking Factbook 2018: An Assessment of the Pharmaceutical Pipeline Summary GBI Research’s latest report “Innovation Tracking Factbook...
Catalog:
CBR Pharma Insights
December 2018
Price: USD 2,995.00
Medical device contract manufacturing is a business model in which a medical device company outsources certain or the whole production activities of...
Catalog:
IQ4I
February 2020
Price: USD 4,950.00
RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective This...
Catalog:
La Merie Publishing
September 2019
Price: USD 2,350.00
